About Kritika Sarmah
Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist.
She earned her bachelor's degree in commerce and is currently pursuing the CFA program.
With her fundamental approach, she aims to help investors identify untapped investment opportunities.
Recent Articles By Kritika Sarmah
2 Chip Stocks to Buy in March, 1 to Sell
Fueled by the surging demand for chips in AI, high-performance computing, smartphones, and automotive applications, the chip market is poised for recovery this year. However, while it might be ideal to buy fundamentally sound chip stocks QUALCOMM (QCOM) and Everspin Technologies (MRAM) next month, avoiding Indie Semiconductor (INDI) is advised, considering its grim fundamentals. Read more...
Top 3 Auto Stocks With Accelerating Profits
The automotive industry is evolving rapidly, with innovations in electric vehicles, AI, and auto parts driving growth and enhancing efficiency. Hence, quality auto stocks PACCAR (PCAR), Gates Industrial (GTES), and Garrett Motion (GTX) might be ideal investments. Read more…
3 Semiconductor Stocks You Need in Your March Investments
The surge in semiconductor demand, coupled with ongoing innovation and government initiatives, positions the semiconductor industry for substantial growth and technological advancement in the coming years. Hence, it might be prudent to invest in fundamentally solid semiconductor stocks Taiwan Semiconductor Manufacturing (TSM), ASE Technology Holding (ASX), and United Microelectronics (UMC). Read on...
3 Tech Stocks Poised to Create Future Gains
The tech landscape is evolving rapidly, with significant growth in various sectors and transformative advancements. Hence, fundamentally strong tech stocks Nidec Corp (NJDCY), Zoom Video Communications (ZM), and Cellebrite DI (CLBT) might be ideal buys for future gains. Read more…
3 Pharma Powerhouses for Long-Term Growth in 2024
Amid evolving technologies and strategic maneuvers, the pharma industry is set for paradigm-shifting growth, propelled by growing funding and drug discovery. Hence, fundamentally strong pharma stocks Collegium Pharmaceutical (COLL), AstraZeneca (AZN), and Merck & Co. (MRK) might be ideal buys this year for long-term growth. Read more…
Eyeing Growth? Check Out These 3 Biotech Stock Buys
Robust government support coupled with rapid tech advancements is bolstering the biotech sector. Hence, investors eyeing growth might buy fundamentally solid biotech stocks Theratechnologies (THTX), Equillium (EQ), and BioMarin Pharmaceutical (BMRN), with massive growth potential. Read on...
Buy, Hold, or Sell These 3 Telecom Stocks?
The telecom sector's pivotal role in bridging digital divides, facilitating online connectivity, and driving technological advancements underscores its significance in the global economy. Hence, let us analyze whether to Buy, Hold, or Sell leading telecom stocks Internet Initiative Japan (IIJIY), Chunghwa Telecom (CHT) and TELUS Corporation (TU)...
3 Telecom Stocks to Invest in Right Now
The telecom market expands through innovation initiatives and rising global traffic. Hence, fundamentally strong telecom stocks Millicom International Cellular (TIGO), Hellenic Telecommunications Organization (HLTOY), and Telefônica Brasil (VIV) might be ideal investments now. Read more…
3 Outsourcing Stocks With Bullish Momentum
In today's fast-paced environment, the outsourcing sector plays a crucial role in meeting the increasing demand for tech and staffing services while also bridging skill gaps. Hence, fundamentally solid outsourcing stocks Randstad (RANJY), Genpact (G), and Scholastic Corporation (SCHL) might be ideal investments. Keep reading...